160 related articles for article (PubMed ID: 38769120)
21. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
22. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
23. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
24. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
25. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.
Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M
BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112
[TBL] [Abstract][Full Text] [Related]
26. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
Shafi T; Zager PG; Sozio SM; Grams ME; Jaar BG; Christenson RH; Boulware LE; Parekh RS; Powe NR; Coresh J
Am J Kidney Dis; 2014 Sep; 64(3):443-51. PubMed ID: 24787760
[TBL] [Abstract][Full Text] [Related]
27. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
Venge P; Arnlöv J; Zethelius B
Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study.
Sabbatinelli J; Giuliani A; Bonfigli AR; Ramini D; Matacchione G; Campolucci C; Ceka A; Tortato E; Rippo MR; Procopio AD; Moretti M; Olivieri F
Cardiovasc Diabetol; 2022 Sep; 21(1):180. PubMed ID: 36088327
[TBL] [Abstract][Full Text] [Related]
29. Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial.
Juraschek SP; Kovell LC; Appel LJ; Miller ER; Sacks FM; Chang AR; Christenson RH; Rebuck H; Mukamal KJ
J Am Coll Cardiol; 2021 Jun; 77(21):2625-2634. PubMed ID: 34045018
[TBL] [Abstract][Full Text] [Related]
30. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
[TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
Gutiérrez OM; Tamez H; Bhan I; Zazra J; Tonelli M; Wolf M; Januzzi JL; Chang Y; Thadhani R
Clin Chem; 2008 Aug; 54(8):1339-48. PubMed ID: 18539645
[TBL] [Abstract][Full Text] [Related]
32. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.
Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Wilson Tang WH; Grodin JL; Passino C; Emdin M
Int J Cardiol; 2019 Feb; 277():166-172. PubMed ID: 30416028
[TBL] [Abstract][Full Text] [Related]
33. High-sensitive troponin T and N-terminal pro-B-type natriuretic peptide independently predict survival and cardiac-related events in adults with congenital heart disease.
Willinger L; Brudy L; Häcker AL; Meyer M; Hager A; Oberhoffer-Fritz R; Ewert P; Müller J
Eur J Cardiovasc Nurs; 2024 Jan; 23(1):55-61. PubMed ID: 36883916
[TBL] [Abstract][Full Text] [Related]
34. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.
Leistner DM; Klotsche J; Pieper L; Stalla GK; Lehnert H; Silber S; März W; Wittchen HU; Zeiher AM;
Clin Chem; 2012 Jan; 58(1):200-8. PubMed ID: 22156668
[TBL] [Abstract][Full Text] [Related]
35. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
36. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
37. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population.
Kavsak PA; Xu L; Yusuf S; McQueen MJ
Clin Chem; 2011 Aug; 57(8):1146-53. PubMed ID: 21700956
[TBL] [Abstract][Full Text] [Related]
38. Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease.
Hicks CW; Wang D; McDermott K; Matsushita K; Tang O; Echouffo-Tcheugui JB; McEvoy JW; Christenson RH; Selvin E
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1583-1591. PubMed ID: 37317848
[TBL] [Abstract][Full Text] [Related]
39. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study.
Wada H; Shinozaki T; Suzuki M; Sakagami S; Ajiro Y; Funada J; Matsuda M; Shimizu M; Takenaka T; Morita Y; Yonezawa K; Matsubara H; Ono Y; Nakamura T; Fujimoto K; Ninomiya A; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
J Am Heart Assoc; 2022 Feb; 11(3):e023464. PubMed ID: 35048713
[TBL] [Abstract][Full Text] [Related]
40. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
